Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Genetics |
RCV001780023 | SCV002016266 | uncertain significance | Neurodevelopmental disorder | 2021-06-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003679071 | SCV004412562 | uncertain significance | not provided | 2024-08-19 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 2501 of the USP9X protein (p.Pro2501Gln). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USP9X-related conditions. ClinVar contains an entry for this variant (Variation ID: 1321943). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |